Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Improvement of hepatorenal syndrome with extracorporeal albumin dialysis mars: Results of a prospective, randomized, controlled clinical trial
- S. Mitzner, J. Stange, R. Schmidt
- MedicineLiver transplantation : official publication of…
- 1 May 2000
It is concluded that the removal of albumin‐bound substances with the MARS method can contribute to the treatment of type I HRS.
Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled study
ECAD appears to be effective and safe for the short‐term treatment of patients with cirrhosis and superimposed acute injury associated with progressive hyperbilirubinemia and may be useful for increasing survival in such patients awaiting liver transplantation.
Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support.
A new membrane separation system that is nearly impermeable to proteins but enables the exchange of water soluble and protein bound toxins by a special membrane and a recycled protein containing dialysate is described.
Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute‐on‐chronic liver failure: The RELIEF trial
At scheduled doses, a beneficial effect on survival of MARS therapy in patients with ACLF could not be demonstrated, however, MARS has an acceptable safety profile, has significant dialysis effect, and nonsignificantly improves severe HE.
Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure.
- S. Mitzner, J. Stange, S. Klammt, P. Peszynski, R. Schmidt, G. Nöldge-Schomburg
- Medicine, BiologyJournal of the American Society of Nephrology…
- 1 February 2001
It is concluded that the molecular adsorbent recirculating system can contribute to the treatment of critically ill patients with liver failure and different underlying diseases.
Schistosoma mansoni: schistosomicidal effect of mefloquine and primaquine in vitro.
Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent recirculating system.
- S. Mitzner, S. Klammt, R. Schmidt
- MedicineTherapeutic apheresis : official journal of the…
- 1 October 2001
It is concluded that MARS can improve multiple organ functions in patients with HRS and one man underwent successful liver transplantation 18 months after the treatment.
Liver support by extracorporeal blood purification: A clinical observation
- J. Stange, S. Mitzner, U. Hopt
- Medicine, BiologyLiver transplantation : official publication of…
- 1 September 2000
It is concluded that in acute excretory failure caused by a chronic liver disease, this treatment provides a therapy option to remove toxins involved in multiorgan dysfunction secondary to liver failure.
Albumin dialysis: single pass vs. recirculation (MARS).
- P. Peszynski, S. Klammt, E. Peters, S. Mitzner, J. Stange, R. Schmidt
- Biology, MedicineLiver
- 1 April 2002
It is shown that MARS is the more effective kind of albumin dialysis for the important substances like bile acids, which are normally included in the commercial albumin solutions.
Molecular adsorbent recirculating system and single-pass albumin dialysis in liver failure – a prospective, randomised crossover study
Both procedures were safe for temporary extracorporeal liver support and in clinical practice routinely assessed plasma bilirubin levels were reduced by both systems, but only MARS affected other paraclinical parameters (i.e., serum bile acids, albumin-binding capacity, and creatinine and urea levels).